Microbiome Discovery & Development Congress

Oxford Global’s Microbiome Discovery and Development Congress will take place on the 12th & 13th June 2017 in Berlin, Germany. This exciting conference showcases world-class speakers discussing novel strategies in microbiome research, challenges of commercialising the microbiome and latest therapeutic trends. Therapeutic areas discussed not only include the gut microbiome, but also dermatology and women’s health. Key speakers include Senior Directors and VPs from J&J, Chr-Hansen and GlaxoSmithKline, and renowned academics and smaller pharmaceutical companies who will provide unique case studies. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions. This congress is co-located with our established 18th Drug Discovery Summit and 5th Discovery Chemistry & Drug Design Congress, which bring together over 250 key opinion leaders and senior industry experts.

Oxford Global’s Microbiome Discovery and Development Congress will take place on the 12th & 13th June 2017 in Berlin, Germany. This exciting conference showcases world-class speakers discussing novel strategies in microbiome research, challenges of commercialising the microbiome and latest therapeutic trends. Therapeutic areas discussed not only include the gut microbiome, but also dermatology and women’s health. Key speakers include Senior Directors and VPs from J&J, Chr-Hansen and GlaxoSmithKline, and renowned academics and smaller pharmaceutical companies who will provide unique case studies. The two-day congress offers an interactive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions. This congress is co-located with our established 18th Drug Discovery Summit and 5th Discovery Chemistry & Drug Design Congress, which bring together over 250 key opinion leaders and senior industry experts.